January 12, 2017 Journal article Open Access

Hugenberg, Verena; Wagner, Stefan; Kopka, Klaus; Schäfers, Michael; Schuit, Robert C; Windhorst, Albert D; Hermann, Sven

JSON-LD (schema.org) Export

{
  "description": "<p>The noninvasive imaging of MMP activity in vivo could have a<br>\nhigh impact in basic research as well as in clinical applications. This approach<br>\ncan be established using radiolabeled MMP inhibitors (MMPIs) as tracers for<br>\nthe detection of activated MMPs by means of PET. However, the complexity of<br>\ndiseases associated with dysregulated MMP expression necessitates the imaging<br>\nof distinct MMPs or MMP subgroups to distinguish their individual role in<br>\nspecific diseases. To this end, selective and potent MMP-13 inhibitors based on<br>\na N,N\u2032-bis(benzyl)pyrimidine-4,6-dicarboxamide core have been synthesized<br>\nand successfully radiolabeled with carbon-11, fluorine-18, and gallium-68.<br>\nSelected radiolabeled candidates were evaluated in vitro and in vivo regarding<br>\ntheir pharmacokinetic properties and metabolic stability.</p>", 
  "license": "http://creativecommons.org/licenses/by/4.0/legalcode", 
  "creator": [
    {
      "affiliation": "European Institute for Molecular Imaging, University of M\u00fcnster, Waldeyerstr. 15, D-48149 M\u00fcnster, Germany and Department of Nuclear Medicine, University Hospital M\u00fcnster, Albert-Schweitzer-Campus 1, Building A1, D-48149 M\u00fcnster, Germany", 
      "@type": "Person", 
      "name": "Hugenberg, Verena"
    }, 
    {
      "affiliation": "Department of Nuclear Medicine, University Hospital M\u00fcnster, Albert-Schweitzer-Campus 1, Building A1, D-48149 M\u00fcnster, Germany", 
      "@type": "Person", 
      "name": "Wagner, Stefan"
    }, 
    {
      "affiliation": "Department of Nuclear Medicine, University Hospital M\u00fcnster, Albert-Schweitzer-Campus 1, Building A1, D-48149 M\u00fcnster, Germany", 
      "@type": "Person", 
      "name": "Kopka, Klaus"
    }, 
    {
      "affiliation": "European Institute for Molecular Imaging, University of M\u00fcnster, Waldeyerstr. 15, D-48149 M\u00fcnster, Germany; Department of Nuclear Medicine, University Hospital M\u00fcnster, Albert-Schweitzer-Campus 1, Building A1, D-48149 M\u00fcnster, Germany and DFG EXC 1003 Cluster of Excellence 'Cells in Motion', University of M\u00fcnster, D-48149 M\u00fcnster, Germany", 
      "@type": "Person", 
      "name": "Sch\u00e4fers, Michael"
    }, 
    {
      "affiliation": "Department of Radiology & Nuclear Medicine, VU University Medical Center Amsterdam, De Boelelaan 1117, 1081 HZ Amsterdam, The Netherlands", 
      "@type": "Person", 
      "name": "Schuit, Robert C"
    }, 
    {
      "affiliation": "Department of Radiology & Nuclear Medicine, VU University Medical Center Amsterdam, De Boelelaan 1117, 1081 HZ Amsterdam, The Netherlands", 
      "@type": "Person", 
      "name": "Windhorst, Albert D"
    }, 
    {
      "affiliation": "European Institute for Molecular Imaging, University of M\u00fcnster, Waldeyerstr. 15, D-48149 M\u00fcnster, Germany and DFG EXC 1003 Cluster of Excellence 'Cells in Motion', University of M\u00fcnster, D-48149 M\u00fcnster, Germany", 
      "@type": "Person", 
      "name": "Hermann, Sven"
    }
  ], 
  "headline": "Radiolabeled Selective Matrix Metalloproteinase 13 (MMP-13) Inhibitors: (Radio)Syntheses and in Vitro and First in Vivo Evaluation.", 
  "image": "https://zenodo.org/static/img/logos/zenodo-gradient-round.svg", 
  "datePublished": "2017-01-12", 
  "url": "https://zenodo.org/record/478813", 
  "keywords": [
    "Selective matrix metalloproteinase inhibitors", 
    "selective MMP-13 inhibitors", 
    "positron emission tomography", 
    "radiotracer"
  ], 
  "@context": "https://schema.org/", 
  "identifier": "https://doi.org/10.1021/acs.jmedchem.6b01284", 
  "@id": "https://doi.org/10.1021/acs.jmedchem.6b01284", 
  "@type": "ScholarlyArticle", 
  "name": "Radiolabeled Selective Matrix Metalloproteinase 13 (MMP-13) Inhibitors: (Radio)Syntheses and in Vitro and First in Vivo Evaluation."
}